Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

Published Date: 13 Dec 2024

Complete responses seen in 43% of patients in expansion cohort of EPCORE CLL-1 study

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Virtual Reality Travel Reduces Cancer Pain.

2.

Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.

3.

The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.

4.

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

5.

the contribution of cortactin to the development of cancer.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot